Skip to main content
SpringerLink
Log in

Post-treatment sarcoma in breast cancer patients

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: Many patients treated for breast cancer with radiotherapy will survive their disease and be at risk for treatment-related sarcoma for many years.

Methods: In order to identify patients with post-treatment sarcoma and define this disease, we examined the records of 99 patients treated for sarcoma with a history of antecedent breast carcinoma. Of these patients, 51 were felt to have a sarcoma unrelated to breast cancer treatment and 48 were felt to have a treatment-related sarcoma (secondary to lymphedema and/or radiation).

Results: Lymphangiosarcoma of the extremity was the most common histologic subtype of post-treatment sarcoma, accounting for 22 of 48 cases (46%). Twenty-six patients (54%) developed nonlymphangiosarcoma post-treatment sarcoma; all of these were radiation-associated sarcomas. The median latency interval between the diagnosis of breast cancer and the development of sarcoma was 11 years (range 4–44) and was not different between the two groups. However, patients with nonlymphangiosarcoma were significantly younger when diagnosed with breast cancer than were those with lymphangiosarcoma of the extremity (median 43 vs. 51 years, p<0.001). The survival of all 48 patients was poor: 5-year survival was 29%. Five-year survival of patients with other types of post-treatment sarcoma was just as poor as those with lymphangiosarcoma of the extremity (30% vs. 28%, p=0.98).

Conclusions: Patients who develop sarcoma after treatment for breast cancer have a poor prognosis whether it occurs as Stewart-Treves syndrome or other types of post-treatment sarcoma. Younger patients may be at higher risk than are older patients for the development of nonlymphangiosarcoma post-treatment sarcoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brady MS, Gaynor JJ, Brennan MF. Radiation-associated sarcoma of bone and soft tissue.Arch Surg 1992;127:1379–85.

    CAS  PubMed  Google Scholar 

  2. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations.Am Stat Assoc J 1958;53:457–81.

    Google Scholar 

  3. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration.Cancer Chemother Rep 1966;50:163–70.

    CAS  PubMed  Google Scholar 

  4. Zar JH.Biostatistical analysis. 2nd ed. Englewood Cliffs, NJ: Prentice-Hall, 1984:61–78.

    Google Scholar 

  5. Hajdu SI.Pathology of soft tissue tumors. Philadelphia, PA: Lea & Febiger, 1979:44–5.

    Google Scholar 

  6. Stewart FW, Treves N. Lymphangiosarcoma in postmastectomy lymphedema.Cancer 1948;1:64–81.

    Google Scholar 

  7. Yap B-S, Yap H-Y, McBride CM, Bodey GP. Chemotherapy for postmastectomy lymphangiosarcoma.Cancer 1981;47:853–6.

    CAS  PubMed  Google Scholar 

  8. Sordillo PP, Chapman R, Hajdu SI, Magill GB, Golbey RB. Lymphangiosarcoma.Cancer 1981;48:1674–9.

    CAS  PubMed  Google Scholar 

  9. Woodward AH, Ivins JC, Soule EH. Lymphangiosarcoma arising in chronic lymphedematous extremities.Cancer 1972;30:562–72.

    CAS  PubMed  Google Scholar 

  10. Ferguson DJ, Sutton HG, Dawson PJ. Late effects of adjuvant radiotherapy for breast cancer.Cancer 1984;54:2319–23.

    CAS  PubMed  Google Scholar 

  11. Schirger A. Postoperative lymphedema: etiologic and diagnostic factors.Med Clin North Am 1962;46:1045–50.

    CAS  PubMed  Google Scholar 

  12. Kaufmann T, Chu F, Kaufman R. Post-mastectomy lymphangiosarcoma (Stewart-Treves syndrome): report of two long-term survivals.Br J Radiol 1991;64:857–60.

    CAS  PubMed  Google Scholar 

  13. Valagussa P, Tancini G, Bonadonna G. Second malignancies after CMF for resectable breast cancer.J Clin Oncol 1987;5:1138–42.

    CAS  PubMed  Google Scholar 

  14. Mindell ER, Shah NK, Webster JH. Postradiation sarcoma of bone and soft tissues.Orthop Clin North Am 1977;8:821–34.

    CAS  PubMed  Google Scholar 

  15. Kim JH, Chu FC, Woodard HQ, Melamed MR, Huvos A, Cantin J. Radiation-induced soft-tissue and bone sarcoma.Radiology 1978;129:501–8.

    CAS  PubMed  Google Scholar 

  16. Tountas AA, Fornasier VL, Harwood AR, Leung PMK. Postirradiation sarcoma of bone. A perspective.Cancer 1979;43:182–7.

    CAS  PubMed  Google Scholar 

  17. Souba WW, McKenna RJ, Meis J, Renjamin R, Raymond AK, Mountain CF. Radiation-induced sarcomas of the chest wall.Cancer 1986;57:610–5.

    CAS  PubMed  Google Scholar 

  18. Taghian A, de Vathaire F, Terrier P, Le M, Auquier A, Mouriesse H, Grimaud E, et al. Long-term risk of sarcoma following radiation treatment for breast cancer.Int J Radiat Oncology Biol Phys 1991;21:361–7.

    CAS  Google Scholar 

  19. Harvey EB, Brinton LA. Second cancer following cancer of the breast in Connecticut, 1935–1982.Natl Cancer Inst Monogr 1985;68: 99–112.

    CAS  PubMed  Google Scholar 

  20. Kato H, Schull WJ. Studies of the mortality of A-bomb survivors. 7. Mortality 1950–1978: Part I. Cancer mortality.Radiat Res 1982;90:395–432.

    CAS  PubMed  Google Scholar 

  21. Tokunaga M, Land CE, Yamamoto T, Asano M, Tokuoka S, Ezaki H, Nishimori I. Breast cancer in Japanese A-bomb survivors.Lancet 1982;2:924.

    CAS  PubMed  Google Scholar 

  22. Kelly PT.Understanding breast cancer risk. Philadelphia, PA: Temple University Press, 1991:103–17.

    Google Scholar 

  23. Hatlinghus S, Rode L, Christensen I, Vaage S. Sarcoma following irradiation for breast cancer.Acta Radiol Oncol 1986;25:239–42.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. From the Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA

    Mary S. Brady MD, Jeanne A. Petrek MD & Murray F. Brennan MD

  2. Mt. Sinai School of Medicine, New York, New York, USA

    Carol F. Garfein MBA (medical student)

Authors
  1. Mary S. Brady MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carol F. Garfein MBA
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jeanne A. Petrek MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Murray F. Brennan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brady, M.S., Garfein, C.F., Petrek, J.A. et al. Post-treatment sarcoma in breast cancer patients. Annals of Surgical Oncology 1, 66–72 (1994). https://doi.org/10.1007/BF02303543

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02303543

Key Words

Search

Navigation